Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: Frequent allelic loss on chromosome 11p and alterations in the APC/β-catenin pathway

American Journal of Pathology

Volumn 160, Issue 3, 2002, Pages 953-962

  Abraham, Susan C ^a   Wu, Tsung Teh ^a   Hruban, Ralph H ^a   Lee, Jae Hyuk ^a   Yeo, Charles J ^a   Conlon, Kevin ^b   Brennan, Murray ^b   Cameron, John L ^a   Klimstra, David S ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; PROTEIN P53;

ACINAR CELL CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BLASTOMA; CHROMOSOME 11P; CLINICAL ARTICLE; FEMALE; GENE LOSS; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL;

EID: 0036120621     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64917-6     Document Type: Article

References (88)

1. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases
2. Histogenesis of pancreatic carcinomas: A study based on 248 cases
3. Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor
4. Alpha fetoprotein-producing acinar cell carcinoma of the pancreas showing multiple lines of differentiation
5. Acinar cell carcinoma of the pancreas. A histologic, immunocytochemical and ultrastructural study
6. Acinar cell carcinoma of the pancreas revealed by Weber-Christian syndrome
7. Functioning pancreatic acinar cell carcinoma: Immunohistochemical and ultrastructural analyses
8. Acinar cell carcinoma of the pancreas with subcutaneous fat necrosis
9. Lipase-secreting acinar cell carcinoma of the pancreas with polyarthropathy. A light and electron microscopic, histochemical, and biochemical study
10. Pancreatic acinar cell carcinoma with subcutaneous and intraosseous fat necrosis
11. Alpha-fetoprotein-producing pancreatic cancer - A case report and review of 28 cases
12. Acinar cell carcinoma of the pancreas. Report of three cases
13. Progression model for pancreatic cancer
14. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
15. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions
16. Overexpression of p53 protein in adenocarcinoma of the pancreas
17. Pancreatic tumours: Molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis
18. DPC4 gene in various tumor types
19. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
20. Only wild-type c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas
21. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation
22. K-ras and p53 gene mutations in pancreatic cancer: Ductal and nonductal tumors progress through different genetic lesions
23. Molecular pathology of invasive carcinoma
24. Allelotype of pancreatic acinar cell carcinoma
25. Acinar cell carcinoma of the pancreas. Report of two cases with complex histomorphologic features causing diagnostic problems
26. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: Frequent alterations in the APC/β-catenin pathway and chromosome 11p
27. Pancreatoblastoma. A clinicopathologic study and review of the literature
28. Microadenocarcinoma of the pancreas - Morphologic pattern or pathologic entity? A reevaluation of the original series
29. Mixed acinar-endocrine carcinomas of the pancreas
30. Mixed exocrine-endocrine tumors of the pancreas
31. Acinar-islet cell tumor of the pancreas: Report of a malignant pancreatic composite tumor
32. Mixed acinar-endocrine carcinoma of the pancreas - A case report
33. Acinar cell carcinoma of the pancreas
34. Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: Study of five cases, one arising in a mediastinal teratoma
35. Alpha-fetoprotein-producing acinar cell carcinoma of the pancreas
36. Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein
37. Increase of serum alpha-fetoprotein in a patient with acinar cell carcinoma of the pancreas
38. Acinar cell carcinoma of the pancreas: A rare case of an alpha-fetoprotein-producing cystic tumor
39. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
40. Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation
41. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections
42. Mutations of the adenomatous polyposis coli gene in the mutation cluster region: Comparison of human pancreatic and colorectal cancers
43. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region
44. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
45. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction
46. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+
47. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas. A newly described and characterized entity
48. Acinar cell carcinoma of the pancreas in a 9-year-old child: Case report with electron microscopic observations
49. Pancreatic acinar cell carcinoma in childhood
50. Pancreatoblastoma in adults
51. Pancreatoblastoma in an adult
52. Pancreatoblastoma in an older adult
53. Pancreatoblastoma in an adult: Its separation from acinar cell carcinoma
54. Adult pancreatoblastoma: A case report and review of the literature
55. Molecular genetics of Beckwith-Wiedemann syndrome
56. Molecular genetics of Wiedemann-Beckwith syndrome
57. Pancreatoblastoma. Three original cases and review of the literature
58. Pancreatoblastoma in a neonate with Wiedemann-Beckwith syndrome
59. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma
60. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver
61. Cytogenetic and molecular studies on six sporadic hepatoblastomas
62. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism
63. Betacatenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma
64. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
65. Loss of heterozygosity and analysis of mutations of p53 in hepatoceliular carcinoma
66. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma
67. No evidence for loss of alleles at 11p in HBV negative hepatocellular carcinomas
68. Frequent loss of heterozygosky on chromosomes 16 and 4 in human hepatocellular carcinoma
69. Biallelic inactivation of the APC gene in hepatoblastoma
70. Somatic mutations of the APC gene in sporadic hepatoblastomas
71. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene
72. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma
73. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas
74. Somatic mutations of beat-catenin play a crucial rope in the tumorigenesis of sporadic hepatoblastoma
75. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibrenectin and poorly differentiated histology in childhood hepatoblastoma
76. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterezygosity
77. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
78. Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation
79. β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis
80. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3
81. Close correlation between, β-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas
82. β-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C infection
83. Expression of E-cadherin-associated molecules (α-, β-, and γ-catenins and p120) in colorectal polyps
84. Expression of nuclear β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas
85. Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma
86. β-catenin mutation in carcinoma of the uterine endometrium
87. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
88. β-catenin in soft tissue sarcomas: Expression is related to proliferative activity in high-grade sarcomas